Synopsis: The share of this chemical company surged by 5%, hitting upper circuit after a dividend proposal and strategic expansion into healthcare technology, boosting investor sentiment.
The shares of this company, primarily engaged in the trading of polymer compounds for cables, plastics, and textiles, are also expanding into specialty chemicals, gaining investor traction after a dividend and expansion strategy.
With a market capitalization of Rs 127 crore, AVI Polymers Ltd’s shares on Monday made a day high of Rs 13.54 per share, up by 5 percent from its previous day’s close price of Rs 12.90 per share, hitting the upper circuit. The share of the company has given a return of 238 percent over the last five years.
What Happened
The Board has also proposed a dividend of up to 50 percent on the paid-up equity share capital for FY26, subject to shareholder approval at the upcoming Annual General Meeting. This recommendation highlights the company’s focus on consistent shareholder rewards, backed by strong profitability and a debt-free balance sheet structure.
In a key strategic move, the company plans to enter the healthcare technology space through its subsidiary AVI AI Technologies. The initiative includes approval of a roadmap and capital allocation for this high-growth segment. The expansion aims to build a diversified AI-driven digital ecosystem and strengthen long-term growth visibility.
AVI Polymers Limited has informed the stock exchanges that its Board meeting is scheduled on April 27, 2026, as per the SEBI Listing Regulations, 2015. The meeting will primarily review and approve key corporate decisions. These include the audited financial results for the quarter and financial year ended March 31, 2026, reflecting the company’s operational performance and recent turnaround.
About the Company
Incorporated in 1993 and headquartered in Ahmedabad, AVI Polymers Ltd is a micro-cap company primarily engaged in the trading of polymer compounds for cables, plastics, and textiles, alongside expanding into specialty chemicals. The company is largely debt-free and has shown recent profit growth, though it has experienced poor long-term sales growth.
Financial highlight: the revenue from operations grew by 348 percent QoQ from Rs 29.50 crore in Q2 FY26 to Rs 132.32 crore in Q3 FY26, and the operating margin stands at 8.15 percent QoQ in Q3 FY26 from 9.80 percent in Q2 FY26. Accompanied by a net profit growth of 206.55 percent to Rs 7.02 crore in Q3 FY26 from Rs 2.29 crore in Q2 FY26, resulting into an EPS of Rs 0.75 per share.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
